Marshall Wace North America’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-63,084	Closed	-$1.94M	–	1708
2021 Q2	$1.94M	Buy	+63,084	New	+$1.93M	0.01%	815
2020 Q4	–	Sell	-42,185	Closed	-$880K	–	1570
2020 Q3	$880K	Sell	42,185 -81,547	-66%	-$1.85M	0.01%	836
2020 Q2	$2.94M	Buy	123,732 +97,769	+377%	+$2.16M	0.02%	481
2020 Q1	$468K	Sell	25,963 -30,477	-54%	-$640K	﹤0.01%	768
2019 Q4	$1.34M	Sell	56,440 -460,203	-89%	-$11.2M	0.01%	664
2019 Q3	$14.2M	Buy	516,643 +14,860	+3%	+$440K	0.08%	207
2019 Q2	$16.6M	Buy	501,783 +275,490	+122%	+$9.44M	0.1%	170
2019 Q1	$7.93M	Buy	226,293 +60,880	+37%	+$2.27M	0.06%	243
2018 Q4	$5.5M	Buy	+165,413	New	+$7.11M	0.05%	238
2018 Q2	–	Sell	-79,058	Closed	-$3.62M	–	1668
2018 Q1	$3.62M	Buy	79,058 +46,318	+141%	+$1.93M	0.02%	644
2017 Q4	$1.3M	Buy	+32,740	New	+$1.29M	0.01%	938
2017 Q2	–	Sell	-15,101	Closed	-$468K	–	1454
2017 Q1	$468K	Buy	+15,101	New	+$405K	﹤0.01%	824